Chronic everolimus treatment of high‐fat diet mice leads to a reduction in obesity but impaired glucose tolerance
Abstract Everolimus, which inhibits mTOR kinase activity and is clinically used in graft rejection treatment, may have a two‐sided influence on metabolic syndrome; its role in obesity and hyperglycemic in animals and humans, however, has been explored insufficiently. This study further determined ho...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2021-04-01
|
| coleção: | Pharmacology Research & Perspectives |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/prp2.732 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|